Report Detail

Request for Sample of this report

Service & Software Global AI Drug Development Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4514646
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global AI Drug Development market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global AI Drug Development market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI Drug Development market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI Drug Development market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI Drug Development market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI Drug Development market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Drug Development
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Drug Development market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited and AiCure, LLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI Drug Development market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Drug Design
Drug Synthesis
Other
Market segment by Application
Tumor
Nervous System
Other
Market segment by players, this report covers
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg，Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Drug Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Development, with revenue, gross margin and global market share of AI Drug Development from 2018 to 2023.
Chapter 3, the AI Drug Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI Drug Development market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Development.
Chapter 13, to describe AI Drug Development research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of AI Drug Development
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Drug Development by Type
    • 1.3.1 Overview: Global AI Drug Development Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global AI Drug Development Consumption Value Market Share by Type in 2022
    • 1.3.3 Drug Design
    • 1.3.4 Drug Synthesis
    • 1.3.5 Other
  • 1.4 Global AI Drug Development Market by Application
    • 1.4.1 Overview: Global AI Drug Development Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Tumor
    • 1.4.3 Nervous System
    • 1.4.4 Other
  • 1.5 Global AI Drug Development Market Size & Forecast
  • 1.6 Global AI Drug Development Market Size and Forecast by Region
    • 1.6.1 Global AI Drug Development Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global AI Drug Development Market Size by Region, (2018-2029)
    • 1.6.3 North America AI Drug Development Market Size and Prospect (2018-2029)
    • 1.6.4 Europe AI Drug Development Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific AI Drug Development Market Size and Prospect (2018-2029)
    • 1.6.6 South America AI Drug Development Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa AI Drug Development Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Insilico Medicine
    • 2.1.1 Insilico Medicine Details
    • 2.1.2 Insilico Medicine Major Business
    • 2.1.3 Insilico Medicine AI Drug Development Product and Solutions
    • 2.1.4 Insilico Medicine AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Insilico Medicine Recent Developments and Future Plans
  • 2.2 Cyclica
    • 2.2.1 Cyclica Details
    • 2.2.2 Cyclica Major Business
    • 2.2.3 Cyclica AI Drug Development Product and Solutions
    • 2.2.4 Cyclica AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Cyclica Recent Developments and Future Plans
  • 2.3 XtalPi Inc.
    • 2.3.1 XtalPi Inc. Details
    • 2.3.2 XtalPi Inc. Major Business
    • 2.3.3 XtalPi Inc. AI Drug Development Product and Solutions
    • 2.3.4 XtalPi Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 XtalPi Inc. Recent Developments and Future Plans
  • 2.4 Exscientia Limited
    • 2.4.1 Exscientia Limited Details
    • 2.4.2 Exscientia Limited Major Business
    • 2.4.3 Exscientia Limited AI Drug Development Product and Solutions
    • 2.4.4 Exscientia Limited AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Exscientia Limited Recent Developments and Future Plans
  • 2.5 AiCure, LLC
    • 2.5.1 AiCure, LLC Details
    • 2.5.2 AiCure, LLC Major Business
    • 2.5.3 AiCure, LLC AI Drug Development Product and Solutions
    • 2.5.4 AiCure, LLC AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AiCure, LLC Recent Developments and Future Plans
  • 2.6 Atomwise
    • 2.6.1 Atomwise Details
    • 2.6.2 Atomwise Major Business
    • 2.6.3 Atomwise AI Drug Development Product and Solutions
    • 2.6.4 Atomwise AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Atomwise Recent Developments and Future Plans
  • 2.7 Biovista Inc.
    • 2.7.1 Biovista Inc. Details
    • 2.7.2 Biovista Inc. Major Business
    • 2.7.3 Biovista Inc. AI Drug Development Product and Solutions
    • 2.7.4 Biovista Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Biovista Inc. Recent Developments and Future Plans
  • 2.8 Breg，Inc.
    • 2.8.1 Breg，Inc. Details
    • 2.8.2 Breg，Inc. Major Business
    • 2.8.3 Breg，Inc. AI Drug Development Product and Solutions
    • 2.8.4 Breg，Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Breg，Inc. Recent Developments and Future Plans
  • 2.9 Numerate
    • 2.9.1 Numerate Details
    • 2.9.2 Numerate Major Business
    • 2.9.3 Numerate AI Drug Development Product and Solutions
    • 2.9.4 Numerate AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Numerate Recent Developments and Future Plans
  • 2.10 Cloud Pharmaceuticals
    • 2.10.1 Cloud Pharmaceuticals Details
    • 2.10.2 Cloud Pharmaceuticals Major Business
    • 2.10.3 Cloud Pharmaceuticals AI Drug Development Product and Solutions
    • 2.10.4 Cloud Pharmaceuticals AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Cloud Pharmaceuticals Recent Developments and Future Plans
  • 2.11 IBM
    • 2.11.1 IBM Details
    • 2.11.2 IBM Major Business
    • 2.11.3 IBM AI Drug Development Product and Solutions
    • 2.11.4 IBM AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 IBM Recent Developments and Future Plans
  • 2.12 NuMedii
    • 2.12.1 NuMedii Details
    • 2.12.2 NuMedii Major Business
    • 2.12.3 NuMedii AI Drug Development Product and Solutions
    • 2.12.4 NuMedii AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 NuMedii Recent Developments and Future Plans
  • 2.13 BenevolentAI
    • 2.13.1 BenevolentAI Details
    • 2.13.2 BenevolentAI Major Business
    • 2.13.3 BenevolentAI AI Drug Development Product and Solutions
    • 2.13.4 BenevolentAI AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 BenevolentAI Recent Developments and Future Plans
  • 2.14 Lam Therapeutics
    • 2.14.1 Lam Therapeutics Details
    • 2.14.2 Lam Therapeutics Major Business
    • 2.14.3 Lam Therapeutics AI Drug Development Product and Solutions
    • 2.14.4 Lam Therapeutics AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Lam Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Drug Development Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of AI Drug Development by Company Revenue
    • 3.2.2 Top 3 AI Drug Development Players Market Share in 2022
    • 3.2.3 Top 6 AI Drug Development Players Market Share in 2022
  • 3.3 AI Drug Development Market: Overall Company Footprint Analysis
    • 3.3.1 AI Drug Development Market: Region Footprint
    • 3.3.2 AI Drug Development Market: Company Product Type Footprint
    • 3.3.3 AI Drug Development Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Drug Development Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global AI Drug Development Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global AI Drug Development Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global AI Drug Development Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America AI Drug Development Consumption Value by Type (2018-2029)
  • 6.2 North America AI Drug Development Consumption Value by Application (2018-2029)
  • 6.3 North America AI Drug Development Market Size by Country
    • 6.3.1 North America AI Drug Development Consumption Value by Country (2018-2029)
    • 6.3.2 United States AI Drug Development Market Size and Forecast (2018-2029)
    • 6.3.3 Canada AI Drug Development Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico AI Drug Development Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe AI Drug Development Consumption Value by Type (2018-2029)
  • 7.2 Europe AI Drug Development Consumption Value by Application (2018-2029)
  • 7.3 Europe AI Drug Development Market Size by Country
    • 7.3.1 Europe AI Drug Development Consumption Value by Country (2018-2029)
    • 7.3.2 Germany AI Drug Development Market Size and Forecast (2018-2029)
    • 7.3.3 France AI Drug Development Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom AI Drug Development Market Size and Forecast (2018-2029)
    • 7.3.5 Russia AI Drug Development Market Size and Forecast (2018-2029)
    • 7.3.6 Italy AI Drug Development Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Drug Development Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific AI Drug Development Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific AI Drug Development Market Size by Region
    • 8.3.1 Asia-Pacific AI Drug Development Consumption Value by Region (2018-2029)
    • 8.3.2 China AI Drug Development Market Size and Forecast (2018-2029)
    • 8.3.3 Japan AI Drug Development Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea AI Drug Development Market Size and Forecast (2018-2029)
    • 8.3.5 India AI Drug Development Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia AI Drug Development Market Size and Forecast (2018-2029)
    • 8.3.7 Australia AI Drug Development Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America AI Drug Development Consumption Value by Type (2018-2029)
  • 9.2 South America AI Drug Development Consumption Value by Application (2018-2029)
  • 9.3 South America AI Drug Development Market Size by Country
    • 9.3.1 South America AI Drug Development Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil AI Drug Development Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina AI Drug Development Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Drug Development Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa AI Drug Development Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa AI Drug Development Market Size by Country
    • 10.3.1 Middle East & Africa AI Drug Development Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey AI Drug Development Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia AI Drug Development Market Size and Forecast (2018-2029)
    • 10.3.4 UAE AI Drug Development Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 AI Drug Development Market Drivers
  • 11.2 AI Drug Development Market Restraints
  • 11.3 AI Drug Development Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 AI Drug Development Industry Chain
  • 12.2 AI Drug Development Upstream Analysis
  • 12.3 AI Drug Development Midstream Analysis
  • 12.4 AI Drug Development Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI Drug Development. Industry analysis & Market Report on AI Drug Development is a syndicated market report, published as Global AI Drug Development Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of AI Drug Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,794.44
    		4,191.66
    		5,588.88
    		3,253.80
    		4,880.70
    		6,507.60
    		539,852.40
    		809,778.60
    		1,079,704.80
    		290,058.00
    		435,087.00
    		580,116.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo